<SEC-DOCUMENT>0001104659-25-023103.txt : 20250312
<SEC-HEADER>0001104659-25-023103.hdr.sgml : 20250312
<ACCEPTANCE-DATETIME>20250312205253
ACCESSION NUMBER:		0001104659-25-023103
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20250312
DATE AS OF CHANGE:		20250312

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MILLICOM INTERNATIONAL CELLULAR SA
		CENTRAL INDEX KEY:			0000912958
		STANDARD INDUSTRIAL CLASSIFICATION:	RADIO TELEPHONE COMMUNICATIONS [4812]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-49833
		FILM NUMBER:		25733536

	BUSINESS ADDRESS:	
		STREET 1:		148-150, BOULEVARD DE LA PETRUSSE
		CITY:			LUXEMBOURG
		STATE:			N4
		ZIP:			L-2330
		BUSINESS PHONE:		3524571451

	MAIL ADDRESS:	
		STREET 1:		148-150, BOULEVARD DE LA PETRUSSE
		CITY:			LUXEMBOURG
		STATE:			N4
		ZIP:			L-2330

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Atlas Investissement
		CENTRAL INDEX KEY:			0001952901
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	BUSINESS ADDRESS:	
		STREET 1:		16 RUE DE LA VILLE L'EVEQUE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75008
		BUSINESS PHONE:		33 1 42 66 99 19

	MAIL ADDRESS:	
		STREET 1:		16 RUE DE LA VILLE L'EVEQUE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75008
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13D/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Atlas Investissement -->
          <cik>0001952901</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>18</amendmentNo>
      <securitiesClassTitle>Common Shares</securitiesClassTitle>
      <dateOfEvent>03/10/2025</dateOfEvent>
      <previouslyFiledFlag>true</previouslyFiledFlag>
      <issuerInfo>
        <issuerCIK>0000912958</issuerCIK>
        <issuerCUSIP>L6388F110</issuerCUSIP>
        <issuerName>MILLICOM INTERNATIONAL CELLULAR S.A.</issuerName>
        <address>
          <com:street1>2, RUE DU FORT BOURBON</com:street1>
          <com:city>Luxembourg</com:city>
          <com:stateOrCountry>N4</com:stateOrCountry>
          <com:zipCode>L-1249</com:zipCode>
        </address>
      </issuerInfo>
      <authorizedPersons>
        <notificationInfo>
          <personName>Denis Klimentchenko</personName>
          <personPhoneNum>44(0)20 7519 7289</personPhoneNum>
          <personAddress>
            <com:street1>Skadden, Arps, Slate, Meagher &amp; Flom</com:street1>
            <com:street2>(UK) LLP, 22 Bishopsgate</com:street2>
            <com:city>London</com:city>
            <com:stateOrCountry>X0</com:stateOrCountry>
            <com:zipCode>EC2N 4BQ</com:zipCode>
          </personAddress>
        </notificationInfo>
      </authorizedPersons>
    </coverPageHeader>
    <reportingPersons>
      <reportingPersonInfo>
        <reportingPersonCIK>0001952901</reportingPersonCIK>
        <reportingPersonNoCIK>N</reportingPersonNoCIK>
        <reportingPersonName>Atlas Investissement SAS</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>I0</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>69666200.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>69666200.00</sharedDispositivePower>
        <aggregateAmountOwned>69666200.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>41.14</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
        <commentContent>(1) Reflects (i) 69,276,200 common shares, par value $1.50 per share ("Common Shares") of Millicom International Cellular S.A., a Luxembourg company (the "Issuer") beneficially owned by Atlas SAS ("Atlas"); and (ii) 390,000 Swedish Depositary Receipts beneficially owned by Atlas, which may be exchanged for Common Shares on a one-for-one basis ("SDRs," together with Common Shares, "Shares"). Atlas Investissement SAS ("Atlas Investissement"), as the controlling shareholder of Atlas, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas. Iliad Holding SAS ("Iliad Holding"), as the controlling shareholder of Atlas Investissement, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas and Atlas Investissement. Xavier Niel, the President of Iliad Holding, Jules Niel, John Niel, Elisa Niel and Joseph Niel (together, the "Niel Family") may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas, Atlas Investissement and Iliad Holding.

(2) The percentage reflected in row 13 in the table above is calculated on the basis of 169,301,471 Shares outstanding as of February 24, 2025 (172,096,305 Shares outstanding, less 2,794,834 Shares held in treasury), as set forth in the last relevant update available on the date hereof on the Issuer's website.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Atlas SAS</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>I0</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>69666200.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>69666200.00</sharedDispositivePower>
        <aggregateAmountOwned>69666200.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>41.14</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
        <commentContent>(1) Reflects (i) 69,276,200 Common Shares beneficially owned by Atlas; and (ii) 390,000 SDRs beneficially owned by Atlas. Atlas Investissement SAS, as the controlling shareholder of Atlas, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas. Iliad Holding, as the controlling shareholder of Atlas Investissement, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas and Atlas Investissement. The Niel Family may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas, Atlas Investissement and Iliad Holding. (2) The percentage reflected in row 13 in the table above is calculated on the basis of 169,301,471 Shares outstanding as of February 24, 2025 (172,096,305 Shares outstanding, less 2,794,834 Shares held in treasury), as set forth in the last relevant update available on the date hereof on the Issuer's website.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Iliad Holding SAS</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>I0</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>69666200.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>69666200.00</sharedDispositivePower>
        <aggregateAmountOwned>69666200.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>41.14</percentOfClass>
        <typeOfReportingPerson>CO</typeOfReportingPerson>
        <commentContent>(1) Reflects (i) 69,276,200 Common Shares beneficially owned by Atlas; and (ii) 390,000 SDRs beneficially owned by Atlas. Atlas Investissement, as the controlling shareholder of Atlas, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas. Iliad Holding, as the controlling shareholder of Atlas Investissement, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas and Atlas Investissement. The Niel Family may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas, Atlas Investissement and Iliad Holding.

(2) The percentage reflected in row 13 in the table above is calculated on the basis of 169,301,471 Shares outstanding as of February 24, 2025 (172,096,305 Shares outstanding, less 2,794,834 Shares held in treasury), as set forth in the last relevant update available on the date hereof on the Issuer's website.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Xavier Niel</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>I0</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>69666200.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>69666200.00</sharedDispositivePower>
        <aggregateAmountOwned>69666200.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>41.14</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>(1) Reflects (i) 69,276,200 Common Shares beneficially owned by Atlas; and (ii) 390,000 SDRs beneficially owned by Atlas. Atlas Investissement, as the controlling shareholder of Atlas, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas. Iliad Holding, as the controlling shareholder of Atlas Investissement, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas and Atlas Investissement. The Niel Family may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas, Atlas Investissement and Iliad Holding.

(2) The percentage reflected in row 13 in the table above is calculated on the basis of 169,301,471 Shares outstanding as of February 24, 2025 (172,096,305 Shares outstanding, less 2,794,834 Shares held in treasury), as set forth in the last relevant update available on the date hereof on the Issuer's website.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Jules Niel</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>I0</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>69666200.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>69666200.00</sharedDispositivePower>
        <aggregateAmountOwned>69666200.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>41.14</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>(1) Reflects (i) 69,276,200 Common Shares beneficially owned by Atlas; and (ii) 390,000 SDRs beneficially owned by Atlas. Atlas Investissement, as the controlling shareholder of Atlas, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas. Iliad Holding, as the controlling shareholder of Atlas Investissement, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas and Atlas Investissement. The Niel Family may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas, Atlas Investissement and Iliad Holding. (2) The percentage reflected in row 13 in the table above is calculated on the basis of 169,301,471 Shares outstanding as of February 24, 2025 (172,096,305 Shares outstanding, less 2,794,834 Shares held in treasury), as set forth in the last relevant update available on the date hereof on the Issuer's website.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>John Niel</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>I0</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>69666200.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>69666200.00</sharedDispositivePower>
        <aggregateAmountOwned>69666200.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>41.14</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>(1) Reflects (i) 69,276,200 Common Shares beneficially owned by Atlas; and (ii) 390,000 SDRs beneficially owned by Atlas. Atlas Investissement, as the controlling shareholder of Atlas, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas. Iliad Holding, as the controlling shareholder of Atlas Investissement, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas and Atlas Investissement. The Niel Family may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas, Atlas Investissement and Iliad Holding.

(2) The percentage reflected in row 13 in the table above is calculated on the basis of 169,301,471 Shares outstanding as of February 24, 2025 (172,096,305 Shares outstanding, less 2,794,834 Shares held in treasury), as set forth in the last relevant update available on the date hereof on the Issuer's website.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Elisa Niel</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>I0</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>69666200.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>69666200.00</sharedDispositivePower>
        <aggregateAmountOwned>69666200.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>41.14</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>(1) Reflects (i) 69,276,200 Common Shares beneficially owned by Atlas; and (ii) 390,000 SDRs beneficially owned by Atlas. Atlas Investissement, as the controlling shareholder of Atlas, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas. Iliad Holding, as the controlling shareholder of Atlas Investissement, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas and Atlas Investissement. The Niel Family may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas, Atlas Investissement and Iliad Holding.

(2) The percentage reflected in row 13 in the table above is calculated on the basis of 169,301,471 Shares outstanding as of February 24, 2025 (172,096,305 Shares outstanding, less 2,794,834 Shares held in treasury), as set forth in the last relevant update available on the date hereof on the Issuer's website.</commentContent>
      </reportingPersonInfo>
      <reportingPersonInfo>
        <reportingPersonNoCIK>Y</reportingPersonNoCIK>
        <reportingPersonName>Joseph Niel</reportingPersonName>
        <memberOfGroup>b</memberOfGroup>
        <fundType>OO</fundType>
        <legalProceedings>N</legalProceedings>
        <citizenshipOrOrganization>I0</citizenshipOrOrganization>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>69666200.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>69666200.00</sharedDispositivePower>
        <aggregateAmountOwned>69666200.00</aggregateAmountOwned>
        <isAggregateExcludeShares>N</isAggregateExcludeShares>
        <percentOfClass>41.14</percentOfClass>
        <typeOfReportingPerson>IN</typeOfReportingPerson>
        <commentContent>(1) Reflects (i) 69,276,200 Common Shares beneficially owned by Atlas; and (ii) 390,000 SDRs beneficially owned by Atlas. Atlas Investissement, as the controlling shareholder of Atlas, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas. Iliad Holding, as the controlling shareholder of Atlas Investissement, may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas and Atlas Investissement. The Niel Family may be deemed to have shared beneficial ownership over the Shares beneficially owned by Atlas, Atlas Investissement and Iliad Holding.

(2) The percentage reflected in row 13 in the table above is calculated on the basis of 169,301,471 Shares outstanding as of February 24, 2025 (172,096,305 Shares outstanding, less 2,794,834 Shares held in treasury), as set forth in the last relevant update available on the date hereof on the Issuer's website.</commentContent>
      </reportingPersonInfo>
    </reportingPersons>
    <items1To7>
      <item1>
        <securityTitle>Common Shares</securityTitle>
        <issuerName>MILLICOM INTERNATIONAL CELLULAR S.A.</issuerName>
        <issuerPrincipalAddress>
          <com:street1>2, RUE DU FORT BOURBON</com:street1>
          <com:city>Luxembourg</com:city>
          <com:stateOrCountry>N4</com:stateOrCountry>
          <com:zipCode>L-1249</com:zipCode>
        </issuerPrincipalAddress>
        <commentText>This Amendment No. 18 ("Amendment No. 18") to Schedule 13D relates to the Common Shares, par value $1.50 per share (the "Common Shares"), of Millicom International Cellular S.A., a Luxembourg company ("Issuer"), and amends and supplements the initial statement on Schedule 13D filed on February 24, 2023, as amended by Amendment No. 1 to the Schedule 13D filed on March 28, 2023, Amendment No. 2 to the Schedule 13D filed on April 26, 2023, Amendment No. 3 to the Schedule 13D filed on May 12, 2023, Amendment No. 4 to the Schedule 13D filed on May 25, 2023, Amendment No. 5 to the Schedule 13D filed on June 2, 2023, Amendment No. 6 to the Schedule 13D filed on July 24, 2023, Amendment No. 7 to the Schedule 13D filed on August 24, 2023, Amendment No. 8 to the Schedule 13D filed on October 2, 2023, Amendment No. 9 to the Schedule 13D filed on November 8, 2023, Amendment No. 10 to the Schedule 13D filed on January 17, 2024, Amendment No. 11 to the Schedule 13D filed on May 23, 2024, Amendment No. 12 to the Schedule 13D filed on July 3, 2024, Amendment No 13. to the Schedule 13D filed on July 22, 2024, Amendment No. 14 to the Schedule 13D filed on August 2, 2024, Amendment No. 15 to the Schedule 13D filed on August 26, 2024, Amendment No. 16 to the Schedule 13D filed on September 9, 2024, and Amendment No. 17 to Schedule 13D filed on October 11, 2024 (as so amended, the "Schedule 13D"). Capitalized terms used but not defined in this Amendment No. 18 shall have the same meanings ascribed to them in the Schedule 13D.</commentText>
      </item1>
      <item2>
        <filingPersonName>Item 2(a) of the Schedule 13D is hereby amended and supplemented, as applicable, as follows:

As of December 16, 2024, Atlas Luxco S.a r.l. was redomiciled from Luxembourg to France and transformed into a French societe par actions simplifiee as Atlas SAS ("Atlas").</filingPersonName>
        <principalBusinessAddress>Item 2(b) of the Schedule 13D is hereby amended and supplemented, as applicable, as follows:

The principal business address of Atlas is 16 rue de la Ville L'Eveque, 75008 Paris, France.</principalBusinessAddress>
      </item2>
      <item3>
        <fundsSource>Item 3 of the Schedule 13D is hereby amended and supplemented by the following:

On March 11, 2025, Atlas acquired an additional 190,000 SDRs for an aggregate purchase price of SEK 56,854,479 (excluding commissions). On March 12, 2025 Atlas acquired an additional 200,000 SDRs for an aggregate purchase price of SEK 59,451,680 (excluding commissions). These acquisitions were purchased with cash on hand.</fundsSource>
      </item3>
      <item4>
        <transactionPurpose>Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following:

On March 10, 2025, Atlas entered into a non-exclusive blind mandate purchase plan in the form of a Purchase Mandate (the "Purchase Mandate"), which terminated in accordance with its terms on March 12, 2025. Pursuant to the Purchase Mandate Atlas was permitted to purchase up to a maximum of 2,723,800 SDRs, subject to certain other pre-agreed pricing and volume limits. The amount and timing of purchases, if any, was permitted to vary and was to be determined based on market conditions, share price and other factors. The program did not require Atlas to purchase any specific number of SDRs or execute any purchases at all through the Purchase Mandate, and Atlas was permitted to modify, suspend or terminate the Purchase Mandate at any time at short notice in accordance with the terms of the Purchase Mandate.

The foregoing description of the Purchase Mandate is qualified in its entirety by reference to the Purchase Mandate, which is filed as Exhibit 17 to the Schedule 13D and incorporated herein by reference.</transactionPurpose>
      </item4>
      <item5>
        <transactionDesc>Except as described in this Schedule 13D or Exhibit 18 attached hereto, the Reporting Persons have not effected any transactions in Shares during the past sixty days.</transactionDesc>
      </item5>
      <item6>
        <contractDescription>Item 6 of the Schedule 13D is hereby amended and supplemented as follows:

The information set forth in Item 4 of this Amendment No. 18 is incorporated herein by reference.</contractDescription>
      </item6>
      <item7>
        <filedExhibits>Item 7 of the Schedule 13D is hereby amended by adding the following exhibit:

17. Purchase Mandate dated March 10, 2025.

18. Trading History During Past Sixty Days.</filedExhibits>
      </item7>
    </items1To7>
    <signatureInfo>
      <signaturePerson>
        <signatureReportingPerson>Atlas Investissement SAS</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Xavier Niel</signature>
          <title>Xavier Niel, President of Iliad Holding SAS itself, President of Atlas Investissement</title>
          <date>03/12/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Atlas SAS</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Anthony Maarek</signature>
          <title>Anthony Maarek, Manager</title>
          <date>03/12/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Iliad Holding SAS</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Xavier Niel</signature>
          <title>Xavier Niel, President</title>
          <date>03/12/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Xavier Niel</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Xavier Niel</signature>
          <title>Xavier Niel</title>
          <date>03/12/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Jules Niel</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Jules Niel</signature>
          <title>Jules Niel</title>
          <date>03/12/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>John Niel</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ John Niel</signature>
          <title>John Niel</title>
          <date>03/12/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Elisa Niel</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Xavier Niel</signature>
          <title>Xavier Niel, Attorney-in-Fact, for and on behalf as Parent/Guardian of Elisa Niel</title>
          <date>03/12/2025</date>
        </signatureDetails>
      </signaturePerson>
      <signaturePerson>
        <signatureReportingPerson>Joseph Niel</signatureReportingPerson>
        <signatureDetails>
          <signature>/s/ Xavier Niel</signature>
          <title>Xavier Niel, Attorney-in-Fact, for and on behalf of as Parent/Guardian of Joseph Niel</title>
          <date>03/12/2025</date>
        </signatureDetails>
      </signaturePerson>
    </signatureInfo>
  </formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.17
<SEQUENCE>2
<FILENAME>tm258864d1_ex17.htm
<DESCRIPTION>EXHIBIT 17
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: left; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 17</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: left">&nbsp;</P>

<P STYLE="margin: 0; text-align: left">&nbsp;<IMG SRC="tm258865d1_ex99-17img001.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">CONFIRMATION OF ASSIGNMENT</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Atlas SAS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">16 rue de la Ville L'&Eacute;v&ecirc;que</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">75008 Paris</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-indent: -35.45pt">Assignment confirmation regarding
purchase of shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reference is made to the correspondence between
Atlas SAS, a French <I>soci&eacute;t&eacute; par actions simplifi&eacute;e</I>, having its registered office at 16, rue de la Ville L'&Eacute;v&ecirc;que,
75008 Paris, France, registered with the Trade and Companies Register under number 935 295&nbsp;519 R.C.S. Paris (the &ldquo;<B>Client</B>&rdquo;)
and DNB Markets, a part of DNB Bank ASA, Sweden Branch, with branch organisation number 516406-0161 (the &ldquo;<B>Contractor</B>&rdquo;
or &ldquo;<B>DNB Markets</B>&rdquo;, and together with the Client, the &ldquo;<B>Parties</B>&rdquo; and each a &ldquo;<B>Party</B>&rdquo;)
regarding the purchase outside the United States of Swedish Depositary Receipts representing shares issued by Millicom International Cellular
S.A. (the &ldquo;<B>Instruments</B>&rdquo; and the &ldquo;<B>Company</B>&rdquo;, respectively).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>1.</B></TD><TD><B>Assignment</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Contractor confirms the following order for
execution of the purchase (the &ldquo;<B>Assignment</B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">A.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">The Client appoints the Contractor, who accepts the Assignment, to endeavor
to purchase outside the United States a number of Instruments in an amount which shall not cause the Client to hold, in aggregate with
any and all Instruments and other type of securities of the Company that the Client owns or will own during the Purchase Period (as defined
in Annex A), directly or indirectly, more than 72,000,000 Instruments and common shares of the Company (the &ldquo;</FONT>Target Number
of Instruments<FONT STYLE="font-weight: normal">&rdquo;), on the Client&rsquo;s behalf and for the Client&rsquo;s account during the Purchase
Period in accordance with the terms and conditions set forth in Annex A.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">B.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">The Contractor is authorized to and will lead-manage the purchases and
make its trading decisions concerning the volume and timing of the purchases of the Instruments independently of the Client. The Client
shall not exercise or attempt to exercise authority over any purchases of Instruments executed by the Contractor pursuant to the Assignment,
and the Client shall not provide to the Contractor&rsquo;s trading team dealing with the Assignment any information or instructions with
respect to the Assignment which would influence the interventions of the Contractor in respect thereof. Additionally, the Assignment does
not permit the Client to exercise any subsequent influence over how, when, or whether to effect any purchases of Instruments under the
Assignment. The Client represents and covenants to the Contractor that it shall not, during the Purchase Period (as defined in Annex A),
alter or deviate from the terms of the Assignment to purchase Instruments or enter into an offsetting transaction or position with respect
to Instruments, notwithstanding the ability for Client to make purchases of, or enter into a concurrent mandate for the purchase of common
shares of the Company in the United States. The Instruments shall be bought by the Contractor on the Swedish Exchange and/or any relevant
trading venues and/or directly from brokers or directly from sellers of the Instruments. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="color: #0E2841; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">C.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">The Contractor will effectuate all purchases based on a best effort
basis but in any event without prejudice to the Maximum Price per Instrument as set forth in Annex A. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-weight: normal">D.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">Promptly after market close on each trading day during the Purchase
Period (as such term is defined in Annex A), the Client will receive an e-mail from the Contractor with the number of Instruments bought
and aggregate price paid for such Instruments (if any) in the reporting format pre-agreed with Client, unless otherwise instructed by
the Client in the form of a standard contract note.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>2.</B></TD><TD STYLE="text-align: justify"><B>Regulatory compliance</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Client shall be solely responsible for its
compliance with all applicable laws and regulations relating to its purchases, including without limitation any disclosure and reporting
obligations, stock exchange regulation, takeover rules, insider trading regulations and market manipulation regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left">&nbsp;<IMG SRC="tm258865d1_ex99-17img001.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">CONFIRMATION OF ASSIGNMENT</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Please note that the Client shall not enter into
this Assignment confirmation and thereby give any orders to purchase Instruments if the Client is in possession of inside information
which is not made public, including where the Company has decided to delay public disclosure of information in accordance with article
17 of the EU Market Abuse Regulation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the avoidance of doubt, the present Assignment
shall not be construed as a plan intended to benefit from the affirmative defense provided by Rule 10b5-1 promulgated by the Securities
and Exchange Commission under the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><B>3.</B></TD><TD STYLE="text-align: justify"><B>FEES</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Client shall pay to the Contractor, on the
relevant Settlement Date (as defined in Annex A and subject to timely notification by the Contractor of the relevant purchase under paragraph
1D) with respect to the Instruments purchased by the Contractor on any trading day, a fee equal to 5 basis point (0.05%) of the daily
purchase amount (equal to the number of Instruments purchased by the Contractor on such day multiplied by the actual price per Instrument
at which such Instruments have been purchased by the Contractor in SEK in respect of that trading day) (the &ldquo;<B>Provision Fee</B>&rdquo;).
The Provision Fee amounts in SEK will be paid by the Client to the Contractor, at the Client&rsquo;s election, either (x) directly in
SEK, or (y) in USD or EUR as converted by the Contractor in SEK at the Contractor's relevant foreign rate of exchange at each relevant
purchase date or at a rate otherwise agreed between the Client and the Contractor from time to time</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>4.</B></TD><TD STYLE="text-align: justify"><B>OTHER</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each of the Parties may terminate the Assignment
by written notice (email being sufficient) with effect on the 1st trading day following the receipt of such notice by the other Party,
provided that, in case of termination by the Client, the Client does not have inside information (as defined under the EU Market Abuse
Regulation) at the time of such notice. Postponement of the Assignment or notice of the same is not termination. Any accrued rights and
liabilities, including fees earned and expenses incurred by the Contractor, shall remain in force after the expiry or termination of the
Assignment. Any termination or postponement of the Assignment by the Client shall include instructions as to whether already placed orders
should be cancelled by the Contractor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Assignment may be amended, modified or waived
by the Parties, as agreed in writing, provided:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">that such amendment, modification or waiver (i) is in writing, and (ii) is made in good faith;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">that at the time of such amendment, modification or waiver the Client shall be deemed to have represented
and warranted to the Contractor that it is not in possession of any inside information (as defined in the EU Market Abuse Regulation),
with respect to the Company, the Instruments and/or the common shares issued by the Company; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">that at the time of such amendment, modification or waiver the Client is not subject to a closed period
as referred to in article 19(11) of the EU Market Abuse Regulation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DNB Bank ASA (&ldquo;<B>DNB</B>&rdquo;) has entered
into an agreement to acquire all the shares of Carnegie Holding AB (the &ldquo;<B>Acquisition</B>&rdquo;). The Parties acknowledge and
agree that, without affecting the Assignment and execution thereof or the rights of the Client under this Assignment, the Contractor shall
have the right, by providing prior written notice to the Client, (i) to assign or transfer this Assignment, including all rights and obligations
hereunder, to an entity within the DNB group of companies, or, alternatively (ii) to cause such DNB&rsquo;s group entity to enter into
a new agreement in terms identical to this Assignment, <I>mutatis mutandis</I>, with the Client with effect from such new agreement, following
any reorganisation or transfer involving the Contractor arising from the Acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>5.</B></TD><TD STYLE="text-align: justify"><B>REGULATORY</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DNB Markets, a part of DNB Bank ASA, Sweden Branch
(&ldquo;<B>DNB Markets</B>&rdquo;) is a business unit within DNB Bank ASA, Sweden Branch, reg. no 516406-0161, (&ldquo;DNB Sweden&rdquo;)
the Swedish branch office of DNB Bank ASA, company reg. no 981 276&nbsp;957 (&ldquo;<B>DNB ASA</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DNB ASA is a Norwegian bank authorized under the
rules of Directive 2014/65/EU (&ldquo;<B>MiFID II</B>&rdquo;) to provide various banking services and investment services relating to
financial instruments, including reception, transmission and execution of orders on behalf of clients, dealing on own account, investment
advice, and placing/underwriting of financial instruments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left">&nbsp;<IMG SRC="tm258865d1_ex99-17img001.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">CONFIRMATION OF ASSIGNMENT</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; text-align: right">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DNB ASA is under the supervision of the Financial
Supervisory Authority of Norway (Finanstilsynet), Revierstredet 3, 0107 Oslo (www. finanstilsynet.no). DNB Sweden is also, for certain
matters, under the supervision of the Swedish Financial Supervisory Authority, in its capacity as host state regulator of the branch.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DNB Markets is obliged to classify its clients
according to MiFID II. On the basis of the information available, each Client will be classified as professional. Thus, each Client will
not benefit from the regulatory protections that apply for non-professional Client. For further information about the classification of
each Client, please see references in paragraph 5.4 below or contact the Contractor. Each Client is responsible for keeping DNB Markets
informed about any changes that could affect its classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DNB Sweden is the controller in relation to personal
data. DNB Sweden will according to these standard terms receive, collect and process personal data in accordance with the DNB Sweden&rsquo;s
privacy policy which can be found at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">https://www.dnb.se/portalfront/dnb_se/AllmanaVillkor/Privacy_policy.pdf</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Personal data will be processed and kept in accordance
with prevailing laws and regulations. The purposes of processing personal data are to execute the agreements entered into between DNB
Markets and its Clients, administration, invoicing/settlement and the marketing of investment products and services. Should there be a
statutory duty to disclose information, personal data may be handed over to public authorities. This also apply for mandatory transaction
reporting pursuant to applicable regulations. Each Client may request information about the processing of personal data carried out by
DNB Sweden and ask what data is registered. Each Client may demand that incorrect or defective information be rectified, and that information
is to be deleted when the purpose of the processing has been completed and the information cannot be used/archived for other purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DNB Markets makes mandatory recordings of all
incoming and outgoing communication in connection with the provision of its services, including e-mails, telephone conversations, text
messages and electronic chats, and may use such records as evidence of each Client&rsquo;s instructions, DNB Market&rsquo;s advice, bring
down meetings etc. Voice recordings and other documentation will be stored by DNB Markets. All records will be deleted as a matter of
routine after a period determined by DNB Markets in accordance with the relevant legislation and internal procedures. Voice recordings
will be stored by the DNB Markets for the retention period stipulated by prevailing legislation, calculated from the recording date, and
will normally be deleted following the expiry of the mandatory storage period. Recordings of conversations with each Client may be traced
by searching, among other things, for the time of the call, the incoming and outgoing telephone numbers and DNB Market&rsquo;s employee
who took part in the call. Government authorities and stock exchanges may, pursuant to laws or regulations, request copies of such records.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Assignment shall be governed by the laws
of Sweden.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The competent courts of Stockholm will have exclusive
jurisdiction to settle any disputes arising out of or related to the validity, interpretation or enforcement of this Assignment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>6.</B></TD><TD STYLE="text-align: justify"><B>REPRESENTATIONS</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -35.45pt">The Client
represents and warrants that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">a.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>it has full power to enter into and perform its obligations under the Assignment and to purchase the Instruments;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">b.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>all authorizations, approvals, consents and licenses required by it (corporate, legal or otherwise) for the purchase of the Instruments
and the transaction contemplated hereby have been obtained, to the extent necessary;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">c.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>it is entering into the Assignment in good faith and shall act in good faith with respect to the Assignment; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">d.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>on the date hereof, it does not possess and is not aware of any inside information (as defined in article 7 of MAR), with respect
to the Company, the common shares of the Company and/or the Instruments;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-weight: normal"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left">&nbsp;<IMG SRC="tm258865d1_ex99-17img001.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">CONFIRMATION OF ASSIGNMENT</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; text-align: right">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">e.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>it shall not disclose to the Contractor any information which may be considered as inside information as defined in article 7 of
MAR, notwithstanding any information relating to the existence or execution of any purchase plan for the purposes of complying with the
Target Number of Instruments requirement as set forth in Article 1A. Should such insider information be disclosed to the Contractor, the
Contractor will take any and all necessary steps to ensure that such inside information will not be transferred nor used on its own behalf
or on behalf of third parties, either directly or indirectly;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">f.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>it shall be responsible for making all declarations, filings and notifications relating to transaction reporting (including as
a person discharging managerial responsibilities, or any of their related parties, under MAR or any similar regulation) and crossing of
thresholds that would be required by the by-laws of the Company or by applicable laws and regulations; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in"><FONT STYLE="font-weight: normal">g.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>it authorizes the recording of the phone conversations by the Contractor during the execution of the Assignment and to produce
such recordings as a proof before any courts or regulatory authorities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>7.</B></TD><TD STYLE="text-align: justify"><B>SANCTIONS</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the purposes of this article, the terms &quot;Sanctioned
Person&quot; and &quot;Sanctions&quot; shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Sanctioned Person</B>&rdquo; means any
person, whether or not having a legal personality that is:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -17.85pt">i.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>listed on any list of designated persons in application of Sanctions;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -17.85pt">ii.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>located in, or organised under the laws of, any country or territory that is subject to comprehensive Sanctions;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -17.85pt">iii.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>directly or indirectly owned or controlled, as defined by the relevant Sanctions, by a person referred to in (i) or (ii) above;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -17.85pt">iv.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>which otherwise is, or will become with the expiry of any period of time, subject to Sanctions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;<B>Sanctions</B>&rdquo; means any economic
or financial sanctions, trade embargoes or similar measures enacted, administered or enforced by any of the following (or by any agency
of any of the following):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -17.85pt">i.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>the United Nations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -17.85pt">ii.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>the United States of America;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -17.85pt">iii.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>the United Kingdom; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -17.85pt">iv.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>the European Union or any present or future member state thereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify; text-indent: -17.85pt">v.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
</FONT>to the extent permitted by laws and regulations, any other jurisdiction relevant applicable to the performance of the Assignment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each Party represents and warrants to the other
party at all times during the term of this Assignment that neither it nor any of its affiliates nor, to the best of its knowledge, any
controlled person, nor any agents is a Sanctioned Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Client understands that the Contractor must
not deal with any transaction for the benefit of a Sanctioned Person or in a manner that would constitute a violation of the Sanctions.
As such, and notwithstanding the fact that the operations have already been carried out, the Contractor may immediately suspend any payment,
promise to pay or authorization to pay (or give any valuable consideration), if the Client is subject to Sanctions or does not comply
with the representations or warranties provided for in this article. Subject to applicable laws, regulations and authorizations of the
competent authorities, the Client may make such payment to a frozen account for the benefit of the Contractor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Either Party may terminate the Assignment with
immediate effect and without compensation if the other party is in breach of the sanctions, representations or warranties provided for
in this clause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 35.45pt"><B>8.</B></TD><TD STYLE="text-align: justify"><B>INDEMNITY AND LIMITATION OF LIABILITY</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Client shall be liable, and shall indemnify
DNB Markets against direct losses (excluding loss of profit), expenses and obligations of any kind incurred by DNB Markets as a direct
result of a breach or rule violation, including interest on overdue payments, fees and charges for internal and external legal assistance.
Such documented losses, expenses and obligations must be paid upon demand for payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left">&nbsp;<IMG SRC="tm258865d1_ex99-17img001.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">CONFIRMATION OF ASSIGNMENT</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; text-align: right">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DNB Markets shall be liable to pay compensation
in the event of gross negligence or wilful default in carrying out the Assignment. If a claim is connected to DNB Markets&rsquo; use of
documents or other information that has been supplied by the Client, or which must be regarded as approved by the Client, DNB Markets
shall not be liable in any event. The same applies to claims that are caused by or connected with DNB Markets having followed the Client&rsquo;s
oral or written instructions. DNB Markets&rsquo; compensation liability towards the Client shall in all circumstances be limited to DNB
Markets&rsquo; consideration as stated in the Agreement. DNB Markets shall in no circumstances be liable for indirect loss of any kind
that may be incurred by the Client, including loss as a result of the Client&rsquo;s agreement or opportunity for an agreement with a
third party either fully or partially lapsing or not being fulfilled. The Client may present a claim towards DNB Markets according to
this provision regardless of if the Client previously has indemnified the Contractor against claims based on the same circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.45pt; text-align: justify"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>9.</B></TD><TD STYLE="text-align: justify"><B>APPROVAL OF THE GENERAL TERMS</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">By signature of the Engagement Letter the Client
also accepts the General Terms of DNB Markets (the &quot;<B>General Terms</B>&quot;) in the condition they exist upon the signing of this
assignment confirmation. The General Terms constitute an integrated part of the Assignment confirmation. In the event of any discrepancy
between the General Terms and this Assignment confirmation, this Assignment shall prevail. The General Terms are available at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">https://www.dnb.no/en/markets/terms-and-agreements/general-business-terms</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additional information about DNB Markets and the
provision of its services can be found at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">https://www.dnb.no/en/markets/terms-and-agreements</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left">&nbsp;<IMG SRC="tm258865d1_ex99-17img001.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">CONFIRMATION OF ASSIGNMENT</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; text-align: right">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>DNB MARKETS</B>, a part of DNB Bank ASA, Sweden Branch&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 48%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 48%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:&nbsp;&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name: </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title: </FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title: </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Atlas confirms its agreement to the terms set out in the Assignment
confirmation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ATLAS SAS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 48%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 48%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Name:&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Title: </FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: left">&nbsp;<IMG SRC="tm258865d1_ex99-17img001.jpg" ALT=""></P>

<P STYLE="margin: 0; text-align: left">&nbsp;</P>

<P STYLE="margin: 0; text-align: right">CONFIRMATION OF ASSIGNMENT</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0; text-align: right">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>ANNEX A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">[*****]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.18
<SEQUENCE>3
<FILENAME>tm258864d1_ex18.htm
<DESCRIPTION>EXHIBIT 18
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 18</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Trading History During Past Sixty Days</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>Trade Date</U></B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>Common Shares<BR>
Purchased/(Sold)</U></B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>Weighted Average Price<BR>
Per Share</U></B></FONT></TD>
    <TD STYLE="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B><U>Name of Entity</U></B></FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">11-Mar-25</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">190,000 </FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">SEK 299.2341</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Atlas</FONT></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">12-Mar-25</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">200,000</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">SEK 297.2584</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: black 1pt solid; border-right: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">Atlas</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The above transactions were made under the Purchase Mandate with respect
to SDRs effected in the open market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm258865d1_ex99-17img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm258865d1_ex99-17img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !# /H# 2(  A$! Q$!_\0
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M?#?_ %SC_P#0GKT:VNH[N"*X@D22&5 Z.O(8'D$5YSXJ_P"2P>&S_P!,X_\
MT)ZB'Q/T9T8OX(O^\OS.O\8#/@K6Q_TX3?\ H!K@_!'@'0M>\*V^HWT4QN)'
MD5C'*4!"NP' ]A7>^+_^1+UO_KPF_P#0#7+?#OQ#HNF^"K2VOM7L+:=9)BT4
MUPBL 9&(R"?2G%ODT(K1IRQ"52UK/?U+,_PE\,O$5C%W&Q_B$V['YUC^&)+_
M ,%^.D\*W-V;K3[I-]L6XVY#$$#G'W6!'T/M7</XP\-(A/\ PD&EG SQ=(Q_
M(')K@[2['C3XLVNH6"2'3]-C&92I ;&[GGIDMP/1?>J7,T[D5(4H2C[*W-?I
MV/613J8*>*Q/3"N9\:^-M/\  NC0ZIJ5O=302W"VX6V52P8JS9^8@8^0]^]=
M-7D?[02J?!&E*XW(=9A##U'ERYH ](\.Z]9^)M!L]8L"WV6ZCWH' #*<D%3C
MN""#[BM,G%>4_"*5]!U?Q)X'N').FW/VFS#'DP2 $?H5/U8UZ7JFH0:5I=SJ
M%TP2WMHFED)/91G^E '*ZQ\4-$T;QQ9^$I8+R:_N9(8P\*H8XVD.%#$L#W!.
M >#7:YKY;MK2YN_%W@SQ;J",+[Q!K_V@ ]$A65 BC/;KCV KZ$\5'Q0;"&/P
MK_9ZW;2XE>^#;4CP>5QU.<4 =!N]J7->/ZP_Q9\*:9<:Y+KNDZQ;6J>9/:?9
M53"#[Q!"J3CZUV2>+VU#X63^++"-$E_LN:[2-\LJR(C$J?4!E(]Z .MSBN)\
M=^,[WPMJ_AFSM;:"5-6OA;2F7.47<HRN#U^8]:Y/P_XG^)7CW0K>YTF/3M'A
M"D2ZA<19\]\G_5(<_*!QDYR<X/45#\2(]1BO/AG'JT\<^HKJ:"XEB7:K/NCR
M0/2@#V@<"C(KDO'?C>'PCIR1PPF\UF\;RM/L4!9YG/&2!SM!(^O2J&J>+-4\
M%^ /[7\4_9KG5W98X[6S4HIE;I&#DYQ@DGV.* .\S29->6"V^+UY8KJZZMI%
MK.R>:NC_ &0,/4(SD$ANQ^;KWK1\/>,=<\;^ GOM"@LK3Q!;W MYX+P-Y4;J
M1NXZC*G(]^.U '9Z9KFFZRL[:;>PW:P2&*4Q-G8XZJ?>M#-?._PO'Q ^QZX/
M#SZ$J#47^T_;%?/F]RN/X?K7J'BSQC?>!OA_'JVJQ6]SJVU(C'"2L33-W'?:
M.OK0!W ;-&1ZUYA'IOQ?*+?-X@T19F&3IK6H\M#Z;P-W'UKTJ%V\F/S]OF[1
MOVJ<;L<X]LT >;_!O_D#:I_U\K_Z *],7I7F?P:_Y!&JD X^U+_Z *]);"KN
M/&*NH_>9QX+^!'T&7<Z6UM+<2?<B0NWT S7G7P=A9-#U&4@XDN H]\+_ /7I
M?B!XOCFM6\/:(XO+^[/E2>0=P0'^$'NQZ>PSFNN\):&/#OARUT\E6E4;YV'1
MI&Y;'MV'L*=K1:?4GF56NN7517XLXR[_ .2[6O\ U[K_ .BVKO=9T>TUS2YK
M"]0-%*.HZJ>S#T(K@[O_ )+K;?\ 7!?_ $6U>F_PFE)[-%4(I^T3[O\ 0\I\
M)ZO>>"_$#^$M;?\ T5W_ -$G)^4%N1@G^%OT;BK/BG_DK_AH?],X_P#T)ZZ7
MQIX4B\4:0T2A4O8@6MY3TS_=/^R>E>7Z/J6H7_CWP[#J:L+NQD6T<O\ >.TL
M1N]^<9[XS6B]Z\D<=6]+EHRVNK??L>N>+S_Q1>N>UC-_Z :X/P/X$T+7_"MO
MJ5_!*]Q(\BLR3LO"NRC@'T%=YXO_ .1,US_KQF'_ (X:R?A;_P B!9]_WL__
M *-:H3:@['54A&>(2DKZ/\R-OA7X6[6MP#_U]/\ XURFLZ)?_#:\AUO1;R6;
M3WD"3P2GGUP<<$$#@XR#7L!!VYZ5YK\4]<M9=*30;5UGO[B928HSN*@=.!W)
M(P.M.+;>I&(HTJ<.>*2:V/1+&Y2]L8+J+/ES1K(N>N",C-616?HEFVG:)863
M_?@@2-N<\A1G]:T!TK)[G?&]E<6O)/V@_P#D2-)_[#,/_HN6O6Z\X^,?AO5_
M%'A73K/1K,W5Q%J<4[H'5<($D!.6([L/?F@HR?&N/"?Q)\)^+UPEI=J-,OVZ
M *WW6)]LY_X *O?&&^GO[32/!5@^+W7KD)(1SY<"D%F/XX^H5JWOB#X7D\5?
M#Z^TJ*+=>"(2VHX!\Y!D#).!GE<D_P 5<QX \,^*;KQF_B;QE8?9KBRTZ*QL
ME,R29./G?Y6.#USG_GH?2@#/^(]E!IOC?X86%LFRWMKV*&)?15>( ?D!77^-
M?'4V@:QI^@:-IAU37]04O%;E]B1)DC>Y],AOR/(P,Y_Q"\,ZSK7C?P5?Z=9-
M/:Z=?++=R"1%$:>8AS@D$\ G@'I47CKPWXEA\;Z3XU\,6L>H7-E;FUGLI) A
M>/+'*DX&?G;OV'!H H>*G^*$G@W6&U*+PK#9&SD\Y86G,@3:<[>HSCUXI_A?
M_DV6?_L"WW_M6K.HR?$/QKI5UI0T"T\/6=Q"R37%Y.)G<$$;41>F>.3V]:B\
M)Z)XHM_A'K?A/4M$%M=6]A<VUFRSHPNC(LA&,'"\L!SZYX[ &Y\'@#\*]#X_
MY9O_ .AM7/?&+_D9OA__ -A<?^A1UU_PUTB_T'P!I6F:G;FWO($821EE;;EB
M>JDCH:Q?B7X:U?7M=\'W.F61N(=/U$3W3!T7RTW(<_,1GH>!0!SO@IT'QAUN
M/Q@&/BK_ )ASO_J?L_/$(/0XS^O?=F3XZ&Z:\\&06K0JSZBQ4SY\OS!L";L=
MN375?$CP,_BS2X[K37^S:_I[>=872G:P8'.PMV!XQZ'GUK*USPOKWQ$^'5O;
MZU9?V/XELY1-$^]2C2J,;@4)PK _@1WQR 6/LWQ?)/\ IO@\X/=)^O\ WS3_
M (8^"M<\)76OW&MW-A*^IW"7"I9,Y5&^?=PRC&=P]>E9=EXN^)FEVZ66J^!'
MO[I!M^U6URNV3T8XR!^GT%=MX3U'Q%J-A/-XDT6/2;CS<0PI.),QX')()YSF
M@#A_@9_QX>*/^PQ)7;>-?"=IXU\.SZ->2/$KD/'-&,M&Z]#CO[CTKSG2K/QK
M\.-=UVWTWPRVN:/?WC7-O+%.%9<D\$'GIP<CJ,@UV=SKWCA/"]G?VWA"-]5>
M=A<V!O$'EQ<X8-G!)^7CW/% '(GQ'\0/AM H\3V<?B#08L*=1M6_?1+P,MGJ
M>?XAU_BKT^R\0:7?V-O>07T)AN(EEC)X)5AD<?0UYOK.K?$/QCH]SH=KX*&E
M)>(89[N]N5*1H>N%ZGTX!KJ])\ :9I^C6-E*\\LEO;QQ-(&VABJ@$X[9QTH
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L@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
